Michael B. Johannesen
Chief Legal Officer & Corporate SecretaryMr. Michael B. Johannesen, also known as Mike, is Chief Legal Officer & Corporate Secretary of Taysha Gene Therapies, Inc. from 2026. Mr. Johannesen has been Chief Legal Officer of Jaguar Gene Therapy, LLC since September 2020. Mr. Johannesen serves as a Chief Legal Officer at Advanced Medicine Partners. Mr. Johannesen served as the Chief Compliance Officer, Senior Vice President and General Counsel at Novartis Gene Therapies, Inc. (formerly known as AveXis, Inc.). since July 11, 2016 until January 2020. Mr. Johannesen served as Vice President, Associate General Counsel & Assistant Secretary from 2008 to April 2016 and Vice President & Assistant Secretary, Commercial and Compliance from 2004 to 2008 at Hospira, where he was responsible for the commercial and compliance functions of Hospira’s legal department. Prior to joining Hospira, he worked as an Attorney in the legal departments of Abbott Laboratories and Whirlpool Corporation as Legal Counsel from 1993 to 1995. He began his legal career at Winston & Strawn LLP in Chicago as Associate from 1990 to 1993. He worked at D'Ancona & Pflaum LLC as Associate from 1995 to 1996. Mr. Johannesen earned his Juries Doctorate degree from the University of Michigan Law School from 1987 to 1990 and a BA in Political Science and Public Administration from the University of Illinois at Urbana-Champaign from 1983 to 1986.
Positions
- Company NameTaysha Gene Therapies, Inc.Stock CodeTSHAPositionChief Legal Officer & Corporate SecretaryColleagues
- SPSean P. NolanCEO & Chairman
- SNSukumar NagendranPresident, Head of Research & Development and Director
- KAKamran AlamCFO & Corporate Secretary
- HCHayleigh CollinsDirector of Corporate Communications & Investor Relations
- PBPhillip B. DonenbergIndependent Director
- LSLaura Sepp-LorenzinoIndependent Director
- SSSean StalfortIndependent Director
